Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

RETRANSMISSION: Group Eleven to be Featured on Radius...

May 9, 2025

Crypto Market Recap: Bitcoin to Hold “Special Status”...

March 6, 2025

Top 5 US Oil and Gas Dividend Stocks...

January 16, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

Cardiex Receives TGA Approval for CONNEQT Pulse Device

June 2, 2025

Joe Cavatoni: Gold’s Key Driver Now, Plus 2026...

November 21, 2025

Mawson Finland Announces Upsize of Brokered Private Placement

February 15, 2025

Radiopharm Theranostics

January 11, 2025

SolGold Secures US$750 Million for Cascabel Project via...

July 16, 2024

Supply Chains in Question as Trump Threatens Tariffs...

November 28, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Deepfake porn crackdown passes in Senate to allow people to sue

      January 14, 2026
    • Secret room to be built at Chinese embassy near cable lines, sparking widespread espionage fears

      January 14, 2026
    • Iran regime opened fire with live ammunition on protesters, doctor says: ‘Shoot-to-kill’

      January 14, 2026
    • Looming war powers Senate vote ramps up pressure on Hawley after MAGA backlash

      January 14, 2026
    • Republican senator condemns alleged Syrian army abuses as ceasefire follows Aleppo fighting

      January 14, 2026

    Categories

    • Business (1,145)
    • Investing (3,870)
    • Politics (4,728)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 sportinvestorsleague.com | All Rights Reserved